tbuckley/cabot-search huggingface dataset:
MA09.11 Acetaminophen Reduces Neoadjuvant Chemo-Immunotherapy Efficacy in NSCLC Patients by Promoting Neutrophil Extracellular Traps Formation
Authors: J. Wu, C. Li, L. Zhang, F. Wang, L. Xu, F. Zhuang, H. Si, Y. She, C. Chen
Journal: Journal of Thoracic Oncology (2023)
MA02.06 Molecular Distribution of Patients with Non-Small Cell Lung Cancer Eligible for Lung Cancer Screening
Authors: J.V. Aredo, J.W. Neal, C.A. Kunder, K.J. Ramchandran, M.S. Das, N.J. Myall, S.S. Han, H.A. Wakelee
Journal: Journal of Thoracic Oncology (2023)
MA04.05 Transcriptomic Features as Determinant of Therapy Response in Neuroendocrine-Transformed Adenocarcinomas Following TKI
Authors: S. Nunes Martins Filho, M. Mikubo, Q. Li, E.L. Stewart, N.-A. Pham, M. Li, J. Weiss, J. Rosen, P. Pal, F. Sherpherd, B. Lok, N. Moghal, G. Liu, M.S. Tsao
Journal: Journal of Thoracic Oncology (2023)
MA03.11 Big Data and Artificial Intelligence for Exploring the Role of Genetic Risk. Family History of Cancer and Lung Cancer. Results from CLARIFY
Authors: V. Calvo, M.E. Vidal, E. Niazmand, E. Carcereny, D. Rodriguez Abreu, M. Cobo, J.M. Trigo, R. López, M. Guirado, C. Camps, A.L. Ortega, R. Bernabe, B. Massutí, R. García Campelo, E. del Barco, M. Martínez, A. Collazo-Lorduy, M. Blanco, M. Torrente, M. Provencio
Journal: Journal of Thoracic Oncology (2023)
MA03.09 Embedding Smoking Cessation into a Potential Lung Cancer Screening Program: Australian Tobacco Control Expert Perspectives
Authors: N.J. Harrison, D. Riddiford-Harland, S. York, H. Marshall, J. Rhee, E. Stone, M.L. Yap, A.R. Sharman, M. Weber, S. McCullough, T. Byrne, C. Paul, J.A. Bowden, B. Bonevski, N.M. Rankin
Journal: Journal of Thoracic Oncology (2023)
MA09.04 Genome-wide Analysis Identifies Nuclear Factor IC as a Novel Transcription Factor and Potential Therapeutic Target in SCLC
Authors: V. Shukla, H. Wang, L. Varticovski, S. Baek, R. Wang, F.J. Echtenkamp, Y. Wang, S.K. Gara, M.R. Zhang, H. Chen, P.S. Meltzer, M.M. Miettinen, L.M. Neckers, W.M. Linehan, G.L. Hager, D.S. Schrump
Journal: Journal of Thoracic Oncology (2023)
MA12.03 New Data from the LungNENomics Project Provide Insights on the Supra-Carcinoid Emerging Variant of Lung Neuroendocrine Tumors
Authors: L. Fernandez-Cuesta, A. Sexton-Oates, E. Mathian, J. Derks, N. Girard, S. Lantuejoul, T. Dayton, N. Alcala, M. Foll
Journal: Journal of Thoracic Oncology (2023)
MA01.04 Randomized Phase II Study of Zoledronate Dosing Every 4 Versus 8 Weeks in Patients With Bone Metastasis From Lung Cancer (Hanshin Cancer Group 0312)
Authors: A. Hata, N. Katakami, T. Nishimura, Y. Hidaka, K. Nishino, M. Mori, T. Hirashima, N. Takase, T. Kaneda, H. Onishi, S. Morita
Journal: Journal of Thoracic Oncology (2023)
EP17.06-01 COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study
Authors: G. Mentrasti, V. Cognigni, T. Galassi, D. Signorelli, E.G. Pizzutilo, F. Martinelli, G. Lo Russo, R. Leporati, P. Ambrosini, R. Giusti, S. D'Amuri, D. Rocco, L. Della Gravara, L. Antonuzzo, S. Fancelli, S. Gori, S. Sernia, M. Ferrari, M. De Tursi, P. Di Marino, M. Di Maio, F. Salerno, L. Zumstein, M. Russano, F. Citarella, V. Adamo, A. Russo, C. Scimone, V. Sforza, A. Morabito, N. La Verde, M.S. Cona, V. Catalano, R. Emili, D. Sarti, F. Morgillo, G. Di Guida, M.B.L. Rocchi, A. Parisi, R. Berardi
Journal: Journal of Thoracic Oncology (2023)
MA12.08 Growth Pattern Evolution of Lung Adenocarcinoma from Primary Tumour to Metastasis in TRACERx
Authors: T. Karasaki, D.A. Moore, A. Huebner, M. Al Bakir, A.M. Frankell, K. Grigoriadis, T.B.K. Watkins, N. McGranahan, C. Swanton, M. Jamal-Hanjani
Journal: Journal of Thoracic Oncology (2023)
EP07.04-26 Real-World Biomarker Testing and Treatment Patterns Identified Using Machine Learning in Early Non-small Cell Lung Cancer
Authors: J.M. Lee, K. Schulze, J. Nedzesky, C. Ng, S. Ogale, A. Johnson, H. Hasan, M.H. Secrest, A. Cohen, E. Castellanos, E. Estola, M. Estevez, J.S. Lee
Journal: Journal of Thoracic Oncology (2023)
P2.17-02 EFfectiveness and Safety Profile of Lurbinectedin in Second-Line Small Cell Lung Cancer: A Real-World Study
Authors: A.K. Ganti, V. Allan, D. Merola, A. Estrin, A. Boccuti, B. Rengarajan, C. Baratta, P. Prince, W. Li, Y. Cao, R.B. D’Agostino, E.M. Poole
Journal: Journal of Thoracic Oncology (2023)
P2.14-03 Outcomes of Chemoimmunotherapy in Patients with ES-SCLC According to Liver Metastasis: A Multicenter Prospective Cohort Study
Authors: Y. Harutani, D. Fujimoto, M. Tamiya, H. Matsumoto, T. Kijima, Y. Sato, J. Sugisaka, Y. Taniguchi, S. Hara, T. Yokoyama, A. Hino, J. Uchida, N. Furuya, H. Daga, H. Ikeda, R. Hiraoka, H. Suzuki, Y. Koh, N. Yamamoto, H. Akamatsu
Journal: Journal of Thoracic Oncology (2023)
EP12.01-17 Association of CYP450 and Drug Efflux Transporters Polymorphism Influence Outcomes of Thai Non-small Cell Lung Cancer Treated with Osimertinib
Authors: T. Majam, C. Sukasem, T. Reungwetwattana, P. Chansriwong, N. Trachu, C. Atasilp, J. Meanwatthana
Journal: Journal of Thoracic Oncology (2023)
EP09.03-01 Outcomes of Extracranial SBRT for Induced Oligopersistant and Oligoprogressive NSCLC Combined with Novel Systemic Therapies
Authors: P. Blumenfeld, E. Tsur, T. Falick Michaeli, H. Nechushtan, Y. Rottenberg
Journal: Journal of Thoracic Oncology (2023)
EP11.03-09 Profile of Patients with NSCLC Who Benefit from Immunochemotherapy. Real-World Data from the Multicenter Polish Lung Cancer Group Study
Authors: M. Knetki-Wróblewska, P. Krawczyk, M. Bryl, T. Jankowski, J. Milanowski, A. Wrona, A. Bandura, R. Dziadziuszko, J. Smok-Kalwat, J. Rok-Knapińska, K. Szydziak-Zwierzyńska, K. Rogoziewicz, K. Stencel, G. Czyżewicz, M. Wójtowicz, M. Wojtukiewicz, E. Kalinka, P. Wysocki, M. Lobacz, H. Pawlik, D.M. Kowalski, M. Krzakowski
Journal: Journal of Thoracic Oncology (2023)
MA05.04 Role of QoL in Treatment Decisions for Patients with ALK+ NSCLC
Authors: H. Law, J.C. King, H.M. Lin, E. Curran, J. Wiens, L. Cruz, J. Blender, E.S. Venanzi, E. Schenk, J.J. Lin
Journal: Journal of Thoracic Oncology (2023)
P2.10-10 Co-occurring Loss of CDKN2A/2B Associated with Worse Survival and Increase Risk of Brain Metastasis in ALK-Rearranged Non-small Cell Lung Cancer
Authors: L. Lara-Mejía, A.F. Cardona, L. Mas, C. Martin, S. Samtani, L. Corrales, G. Cruz-Rico, J. Remon, M. Galvez-Nino, R. Ruiz, E. Rios-Gracia, F. Tejada, R. Rosell, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
P1.28-05 Cessation of Marrow Proliferation on FLT-PET with Low RT doses during chemoRT for NSCLC Correlates with Lymphocyte Decline
Authors: M.P. MacManus, E. Prins, F. Hegi-Johnson, R. Hicks, J. Callahan, T. Akhurst, J. Xie, S. Everitt
Journal: Journal of Thoracic Oncology (2023)
EP04.01-07 Optimal Predictors for Lung Cancer Using High-Resolution CT
Authors: H. Notsuda, H. Oshio, K. Onodera, T. Watanabe, Y. Watanabe, T. Suzuki, H. Oishi, H. Niikawa, M. Noda, Y. Okada
Journal: Journal of Thoracic Oncology (2023)
EP08.02-23 Is Early Cessation of Chemoradiotherapy Preventing Access to Adjuvant Immunotherapy for Patients with Stage III NSCLC?
Authors: M.P. MacManus, M. Alexander, J. Xie, D. Ball, B. Solomon, N. Plumridge, M. Shaw, S. Harden, F. Hegi-Johnson, S. Siva, T. John, A. Officer, N. Wallace
Journal: Journal of Thoracic Oncology (2023)
P2.09-04 Treatment Adherence Disparities and Clinical Outcomes of Osimertinib among Ethnic-Minority Patients with EGFR-Mutated NSCLC
Authors: M. Lee, E. Miao, C. Zhang, X. Xue, S. Tuckman, B. Halmos, H. Cheng
Journal: Journal of Thoracic Oncology (2023)
P1.21-10 PD-1 and Interleukin-10-Receptor Expression by T Lymphocytes in Malignant and Benign Pleural Effusions
Authors: B. Mosleh, B. Hammer, D. Bernitzky, M. Kramer, S. Ayazseven, S. Geleff, M. Idzko, M.A. Hoda, D. Gompelmann
Journal: Journal of Thoracic Oncology (2023)
P2.31-10 Clinical Outcomes of Real-World Treatment for Metastatic EGFRm NSCLC after Osimertinib and Platinum-Based Chemotherapy
Authors: J. Patel, J. Meng, H. Le, Y. Tanaka, S. Phani, C. Wu, M. Salas, D. Sternberg, S. Esker, H. Sun, C. Lieb, K. Reckammp
Journal: Journal of Thoracic Oncology (2023)
EP08.02-14 Prognostic Role of Baseline PET/CT Parameters in Frail Patients with Inoperable Node-Positive Stage IIB-IIIC/Recurrent NSCLC
Authors: A. Schäfer, J.E. Guggenberger, A. Holzgreve, J. Taugner, L. Käsmann, M. Unterrainer, N.-S. Schmidt-Hegemann, C. Belka, F. Manapov, C. Eze
Journal: Journal of Thoracic Oncology (2023)
EP11.03-32 Dose the Histological Subtype of NSCC-NOS Affect the Efficacy of 1st-Line PD-1/PD-L1 Inhibitors with or without Chemotherapy?
Authors: T. Hirano, M. Morise, S. Hori, T. Hashimoto, S. Ozone, J. Koyama, I. Tanaka, M. Sato, T. Kimura, Y. Kondoh, M. Ishii
Journal: Journal of Thoracic Oncology (2023)
P2.25-03 Functional Independence of Older Adults after Lung Cancer Surgery: Final Analysis of a Prospective Observational Study
Authors: T. Mizutani, H. Takei, H. Kunitoh, M. Wakabayashi, Y. Sekino, M. Tsuboi, N. Ikeda, H. Asamura, M. Okada, M. Takahama, Y. Ohde, J. Okami, S. Shiono, K. Aokage, S. Watanabe
Journal: Journal of Thoracic Oncology (2023)
P2.05-16 Immune Suppressive Microenvironment in Liver Metastases Contributes to Organ-Specific Response of Immunotherapy
Authors: J.-Y. Deng, R.-W. Zhong, Q. Gou, Z.-H. Chen, M.-Y. Yang, X.-R. Yang, L. Yang, C.-R. Xu, Y.-L. Wu, Q. Zhou
Journal: Journal of Thoracic Oncology (2023)
P1.22-03 Ventana ALK (D5F3) Immunohistochemistry Improves the Accuracy of Pathologic Assessment after Neoadjuvant ALK-TKIs for ALK-Positive NSCLC
Authors: L.-X. Yan, Q. Cui, Q. Zhou, X.-N. Yang, W.-Z. Zhong, Z.-Y. Liu, Q.-L. Zhang, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
P2.06-06 Study Design to Assess Anti-TIGIT Mab Combination with Dostarlimab vs Pembrolizumab or Dostarlimab Monotherapy in NSCLC
Authors: D.R. Spigel, B.C. Cho, M. Reck, K. Nakagawa, S. Wimalasundera, E. Parkhomenko, R. Parasrampuria, L. Parker, A. Khaled, M. Satouchi
Journal: Journal of Thoracic Oncology (2023)
EP04.05-05 Singapore Lung Cancer Screening through Integrating CT with Other Biomarkers (SOLSTICE), A Single Arm Lung Cancer Screening Study
Authors: G. Lai, G.S.K. Ooi, C.W. Too, M. Huang, C.M.L. Chia, S.P.L. Saw, W.C. Tan, S.M. Haja Mohideen, W.S. Ong, Z.Y. Ng, B.-H. Ong, A. Devanand, D.S.W. Tan, D.W.-T. Lim
Journal: Journal of Thoracic Oncology (2023)
EP12.01-55 Aumolertinib as First-line Treatment in EGFR-Mutant Pulmonary Adenosquamous Carcinoma: A Multicenter, Single-Arm, Prospective Study (ARISE)
Authors: G. Lin, Q. Chu, L. Huang, L. Wu, Y. Yu, Z. Liu, D. Huang
Journal: Journal of Thoracic Oncology (2023)
P1.22-01 Clinical Characteristics and Biomarkers in Lung Cancer: A Comparison Between Screened and Non-Screened Cohorts
Authors: M. Pasquinelli, Z. Ziqiao Xu, F. Weinberg, K. Kovitz, C. Kapp, L. Liu, M. Munoz, A.G. Guzman, M. Koshy, A. Salahudeen, L. Feldman, R. Nguyen
Journal: Journal of Thoracic Oncology (2023)
EP11.03-19 Anti-angiogenic Therapy or Immunotherapy? A Multicenter Study of Patients with Advanced NSCLC with EGFR / HER2 exon 20 Insertion Mutations
Authors: T. Chu, J. Li, M. Xie, R. Zhao, H. Qiang, Q. Chang, J. Qian, H. Lu, Y. Shen, Y. Han, C. Su
Journal: Journal of Thoracic Oncology (2023)
EP07.01-28 Local Control &amp; Toxicity Results of Stereotactic Body Radiotherapy in Central Lung Tumors
Authors: Y. Babayigit, O. Bascik, S. Öz, Y. Arslan, S. Duru Birgi, E. Gümüstepe, Y. Kahya, S. Akyürek
Journal: Journal of Thoracic Oncology (2023)
EP07.05-03 Neoadjuvant Chemotherapy or Chemo-IO in Resectable KRAS-Mutated Non-small Cell Lung Cancer (NSCLC) Patients: Single Center Experience
Authors: K. Wang, F.R. Rojas Alvarez, C.H. Leung, H. Kemp, W.E. Lewis, C.A. Arrechedera, L.M. Solis Soto, G. Blumenschein, B. Sepesi, F. Skoulidis, J.V. Heymach, D.L. Gibbons, J. Zhang, I.I. Wistuba, J.J. Lee, A. Weissferdt, S.G. Swisher, A. Pataer, T. Cascone, M.V. Negrao
Journal: Journal of Thoracic Oncology (2023)
P1.21-16 NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy
Authors: K. Danilov, D. Bansal, C. Ward, A. Al-Obaidi, T. Pluard, A. Tarasov, I. Valiev, V. Kushnarev, A. Makarova, A. Butusova, A. Love, K. Nomie, A. Bagaev, J. Subramanian, N. Fowler
Journal: Journal of Thoracic Oncology (2023)
EP07.04-04 High-Risk Clinicopathologic and Genomic Features of Recurrence in Stage I Lung Adenocarcinoma
Authors: C.N. Fick, E.G. Dunne, B. Mastrogiacomo, K.S. Tan, N. Toumbacaris, P.S. Adusumilli, G. Rocco, D. Molena, J. Huang, B.J. Park, M.J. Bott, V.R. Rusch, S. Sihag, J.M. Isbell, D.R. Jones
Journal: Journal of Thoracic Oncology (2023)
P1.11-01 Utility of ctDNA Monitoring during Surveillance in Surgically Resected NSCLC Patients
Authors: S. Ohara, K. Suda, E. Kalashnikova, S. Sudhaman, S.K. Cheung, M. Krainock, J. Feeney, H. Sethi, M.C. Liu, J. Soh, Y. Tsutani, T. Mitsudomi
Journal: Journal of Thoracic Oncology (2023)
EP05.01-14 Survival in Patients with Malignant Pleural Effusion Treated with a Tunneled Pleural Catheter Compared to the Lent Prognostic Score Scale
Authors: R. Lopez-Castro, E. Rodríguez-Flórez, B. de Vega-Sánchez, E. Solís García, A. Fuentes-Martin, C. Rodriguez-Dupuy, S. Fernandez-Gay, C. San José García, H. Borrego-Pintado, C. Disdier-Vicente
Journal: Journal of Thoracic Oncology (2023)
P1.25-14 Delayed Recovery Time of Percutaneous Oxygen Saturation After Stair-climbing as a Predictor of Postoperative Complications
Authors: K. Takei, H. Konno, D. Yamaguchi, S. Imamura, K. Matsushima, M. Asami, T. Masuda, S. Katsumata, K. Maeda, H. Kojima, M. Isaka, Y. Ohde
Journal: Journal of Thoracic Oncology (2023)
EP07.01-06 Lead-Time Bias in Surgically Resected Non-Small Cell Lung Cancer (NSCLC) Diagnosed Through Different Pathways of Care
Authors: O. Akinbobola, W. Liao, N.R. Faris, C. Fehnel, J. Goss, C.J. Shepherd, T. Qureshi, S. Peppers, A. Harris, A. Porter, A. Patel, F. Caro, J. Roma, A.T. Matthews, M.A. Ray, M.P. Smeltzer, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2023)
EP10.01-15 Sarcopenia as a Predictive Factor of Carboplatin Toxicity in Patients with Advanced Non-small Cell Lung Cancer
Authors: J. Turcott, S.M. Miyagui, E. Caballe-Perez, S. Salvador Gutiérrez Torres, D. Daniela Cardenas-Fernandez, E. Eduardo Rios-Garcia, A.F. Cardona, C. Christian Rolfo, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
MA11.08 IMpower010: Exploratory Analysis of Tumour Mutational Burden and Disease-Free Survival with Adjuvant Atezolizumab in NSCLC
Authors: E. Felip, M. Srivastava, M. Reck, H. Wakelee, N. Altorki, E. Vallieres, R. Liersch, S. Oizumi, H. Tanaka, J.T. Hamm, S. Novello, S. McCune, L. Molinero, V. McNally, S. Morris, M. Ballinger, H. Li, W. Zou, B.J. Nabet, E. Bennett, B.J. Gitlitz, C. Zhou
Journal: Journal of Thoracic Oncology (2023)
P1.12-08 Characterization of MET Exon 14 Skipping Analog (Y1003) in Non-Small Cell Lung Cancer (NSCLC)
Authors: S.Y. Kim, H.G. Narvel, N. Gandhi, J.A. Marks, J.P. Zaemes, S. Dacic, S.V. Liu, C. Kim, P.C. Ma, K. Reckamp, R. Feldman, M. Nagasaka, H. Khan, D. Uprety, J. Xiu, A. Vanderwalde, H. Cheng, B. Halmos
Journal: Journal of Thoracic Oncology (2023)
P2.03-02 Hybrid Immuno-RT (EclipseRT) for Bulky Tumors: Low-Dose Radiotherapy with Partial Tumor SBRT in Mice and Patients
Authors: R. Luo, M. Yu, Z. Su, K. Kang, Y. Wu, Z. Yao, W. Xiu, X. Zhang, F. Na, Y. Zhang, J. Li, Y. Yu, Y. Li, S. Zeng, L. Zhou, Y. Xu, Y. Liu, F. Peng, J. Wang, R. Zhong, W. Luo, B. Zou, Y. Gong, M. Huang, S. Bai, J. Xue, D. Yan, Y. Lu
Journal: Journal of Thoracic Oncology (2023)
P1.09-02 Midkine Dependent Immunosuppressive Environment in Cerebrospinal Fluid May Promote Leptomeningeal Metastases of EGFR mutant NSCLC
Authors: Y.-S. Li, K. Yin, W.-P. Lai, M.-M. Zheng, H.-Y. Tu, Z. Wang, L. Zeng, B.-Y. Jiang, J.-J. Yang, Q. Zhou, W.-Z. Zhong, X.-N. Yang, H.-J. Chen, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
EP11.03-41 Successful Treatment with Pembrolizumab Alone for SMARCA4-deficient Lung Sarcomatoid with a High-TMB and PD-L1(+) A Case Report
Authors: Y. Deng, S. Cai, C. Huang, R. Jia, W. Liu, Z. Sui, Z. Yu, X. Guo
Journal: Journal of Thoracic Oncology (2023)
P2.23-02 Prospective Observational Study of Cachexia and Its Effect on Systemic Therapy in Patients with Previously-Untreated Advanced NSCLC (NEJ050A)
Authors: N. Furuya, K. Miura, T. Shukuya, R. Morita, A. Kisohara, A. Mouri, S. Watanabe, H. Tanaka, A. Hirata, T. Hakozaki, K. Hamai, N. Matsumoto, K. Watanabe, H. Ashinuma, E. Miyauchi, K. Sugano, S. Hosokawa, H. Asahina, R. Koyama, T. Tamura, N. Kanaji, T. Nakagawa, M. Kamimura, K. Isobe, T. Tsuda, S. Morita-Tanaka, D. Arai, H. Nagashima, D. Jingu, T. Ibe, K. Usui, M. Matsumoto, Y. Masui, M. Miyazaki, S. Morita, K. Kobayashi, K. Takahashi
Journal: Journal of Thoracic Oncology (2023)
P2.17-07 Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis
Authors: B. Halmos, P. Lammers, M. Patel, I. Shapira, L. Shunyakov, D. Slater, C. Labbé, N. Naveh, A. Boccuti, R. Hanvesakul, W. Li, B. Rengarajan, F. Badin
Journal: Journal of Thoracic Oncology (2023)
EP02.04-05 Xenotransplanted Lung Tumors Display Variable Pleomorphic Patterns in Immunosuppressed BALB/c Mice
Authors: N. Tan-Liu, M. Cabanatan, D. Macapagal, K. Fernandez, C. Nalo-Ochona, M.I. Idolor, M. Russelle Alvarez, C.B. Lebrilla, J.F. Rabajante, R. Nacario, G. Completo, M.T. Barzaga, F.M. Heralde
Journal: Journal of Thoracic Oncology (2023)
EP07.02-06 MIDRIXNEO-LUNG: Safety and Immunogenicity of a Neoantigen-Presenting Autologous Dendritic Cell Therapy in Resected NSCLC Patients
Authors: J. Ingels, L. De Cock, D. Stevens, K. Weening, V. Surmont, J. Vandorpe, F. Impens, B. Menten, K. Vermaelen, B. Vandekerckhove
Journal: Journal of Thoracic Oncology (2023)
P2.04-03 EGRET: First-in-human Study of the Novel Antibody-drug Conjugate AZD9592 ± Anti-cancer Agents in Advanced Solid Tumours
Authors: C. Aggarwal, B. Solomon, A. Spira, E. Massarelli, S.C.m. Lau, X. Le, C. Rolfo, D. Planchard, E. Felip, Y.-L. Wu, M.-J. Ahn, K. Goto, A. Azaro, D. Lissa, O. Hamid, L. McGrath, R. Maudsley, C. Hayward, A. Mathewson, F. Arnaldez, I. Grenga, C. Azzoli
Journal: Journal of Thoracic Oncology (2023)
P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel
Authors: M. Brandao, E. Prisciandaro, E. Xenophontos, A. Mariolo, A.H. Sadeghi, A.R. Filippi, A. Levy, A. Bandura, C. Caramella, C. Dickhoff, C. de Margerie-Mellon, C. Faivre-Finn, D. Portik, D. Sanchez-Lorente, D. De Ruysscher, E. Smit, E. Gobbini, E. Fadel, E. Ruffini, E. Olmetto, F. Cortiula, I. Bahce, I. Houda, I. Opitz, J. Naidoo, J. Edwards, J. Remon, J.C. Benitez, J.C. Trujillo, J. Derks, K. Amrane, K. Hartemink, K. Stathopoulos, L. Hendriks, M. Iglesias, M. Occhipinti, M. Guckenberger, N. Giaj Levra, N. Girard, N. Reguart, O. Mercier, P. Bironzo, P. Hofman, R. Horsleben Petersen, R. De Angelis, R. Abgral, S. Terrisse, S. Popat, T. Pierret, T. Gerriet Blum, U. Ricardi, V. Dionisi, T. Berghmans, A.-M. Dingemans
Journal: Journal of Thoracic Oncology (2023)
P1.26-07 Trisegmentectomy is Indicated for Non-Small Cell Lung Cancer in the Left Upper Division
Authors: J. Herrera-Zamora, M. McAllister, R.R. Barcelos, R. Leo, E.A. Sugarbaker, A. Singh, E. Mazzola, P.A. Ugalde Figueroa, M.M. Rochefort, A. Coppolino, C.T. Ducko, D.C. Wiener, A. White, C.J. McNamee, J.O. Wee, M.B. Marshall, S.J. Mentzer, R. Bueno, M.T. Jaklitsch, S.J. Swanson
Journal: Journal of Thoracic Oncology (2023)
P2.19-01 First-in-Human Phase 1 Trial of VT3989, a First-in-Class YAP/TEAD Inhibitor in Patients with Advanced Mesothelioma
Authors: T. Yap, J. Desai, I. Dagogo-Jack, M. Millward, H.L. Kindler, A.W. Tolcher, S. Frentzas, A.L. Body, A. Thurston, L. Post, F.A. Dorr, D.J. Kwiatkowski
Journal: Journal of Thoracic Oncology (2023)
EP04.01-02 Volatile Organic Compounds in Exhaled Breath as Biomarkers for Lung Cancer. A Screening-Based Study in High-Risk Participants
Authors: A. Catino, A. Di Gilio, M. Nisi, G. D'Alonzo, J. Palmisani, N. Varesano, D. Bafunno, S. De Summa, G. De Gennaro, D. Galetta
Journal: Journal of Thoracic Oncology (2023)
MA15.08 Multicenter Phase II Trial of LN-145 TIL Cell Therapy plus Pembrolizumab in Patients with ICI-Naïve Metastatic NSCLC
Authors: A.J. Schoenfeld, K. He, J. Chesney, E. Garon, J. Nieva, A. Sacher, S. Lee, F. Graf Finckenstein, R. Fiaz, M. Catlett, G. Chen, V. Gontcharova, B.C. Creelan
Journal: Journal of Thoracic Oncology (2023)
EP07.05-16 MPR and pCR Rates after Neoadjuvant Chemo-immunotherapy for Stage III Non small Cell Lung Cancer.
Authors: D.L. Stroyakovsky, D.D. Sekhniaidze, N.A. Savelov, I.A. Demidova, D.Y. Kanner, M.I. Popov, A.S. Danilova, Y. Akhmadiyarova, I.S. Kupaeva, M.A. Makhina, D.A. Blinov, I.A. Zaberezhny, A.A. Anteev, M.V. Voronin, M.A. Agasiev
Journal: Journal of Thoracic Oncology (2023)
EP07.01-08 Development of a Shared Decision-Making Tool for Adjuvant Treatment for Patients with Resected Non-Small Cell Lung Cancer
Authors: C. Soto Jacome, I. Hargraves, Y. Ashara, S. Algarin Perneth, A. Sivly, D. Gravholt, C. Sagen, J. Brito, V. Montori, K. Leventakos
Journal: Journal of Thoracic Oncology (2023)
EP02.02-02 Transcriptomic Response to Tumor Treating Fields (TTFields) Across Tumor Types
Authors: K. Wainer Katsir, G. Lavy-Shahaf, H. Fishman, H. Ene, R. Frechtel-Gerzi, A. Martinez-Conde, E. Dor-On, S. Davidi, S. Jacobovitch, I. Tzchori, Y. Porat, L. Ding, M.D. Story, R. Du, U. Kahlert, L. Mannarino, F. Mirimao, M. Lupi, M. D’Incalci, A. Haber, M. Giladi, U. Weinberg, Y. Palti
Journal: Journal of Thoracic Oncology (2023)
EP13.03-01 Correlation of Immune-Related Adverse Events to Efficacy of PD-1/PD-L1 Inhibitors in Small Cell Lung Cancer: A Multi-center Retrospective Study
Authors: J. Zhang, A. Gao, J. Li, S. Wang, H. Sun, Y. Sun, Q. Cheng, J. Wu, Y. Ge, Y. Sun
Journal: Journal of Thoracic Oncology (2023)
EP11.02-08 Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)
Authors: J. Nguyen, G. Quere, R. Descourt, M. Geier, H. Babey, P. Saliou, J. Picard, E. Dhamelincourt, T. Fave, Q. Laune, A. Simaki, E. Renaud, D. Cornec
Journal: Journal of Thoracic Oncology (2023)
EP11.03-38 Comparison of Real-World Outcomes in aNSCLC Patients Receiving 1L Immunotherapy Alone or in Combination with Chemotherapy
Authors: S.M. Lim, H.A. Jung, D.H. Lee, S. Lim, M.J. Lee, H. Yu, S. Yoon, K-p. Kim, H. Jeong, J. Kim, X. Zhao, K.C. Toh, D. Kim
Journal: Journal of Thoracic Oncology (2023)
EP12.01-65 Prognostic Value of Sequential Liquid Biopsy (LB) after Osimertinib Among Hispanic Patients with Advanced EGFR-Mutant NSCLC
Authors: A. Cardona, J. Zuluaga, L. Rojas, O. Arrieta, A. Ruiz-Patiño, J. Rodríguez, D. Chamorro, L. Corrales, C. Martin, L. Viola, L. Raez, C. Vargas, J. Otero, H. Carranza, R. Motta, C. Rolfo, R. Rossell
Journal: Journal of Thoracic Oncology (2023)
EP03.06-06 KRAS-B: Molecular Epidemiology and Clinical Outcomes of KRAS-Mutant Non-small Cell Lung Cancer (NSCLC) in Brazil
Authors: P. De Marchi, P. Aguiar, R. Duarte Paes, T. Montella, N. Gimenes Afonso, I. Santos Negreiros, F.L. Vasconcelos Visani, I. Favato Barcellos, G.G. Viana Veloso, M. Xavier Reis, C. Mathias, M. Zalis, R. Dienstmann, C. Gil Ferreira
Journal: Journal of Thoracic Oncology (2023)
P1.23-04 Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC
Authors: K. O'Byrne, K.B. Shanmugasundaram, E. Ahmed, A. Kulasinghe, J. Monkman, J.A. Fletcher, P.N. Mainwaring, M.K. Masud, H. Park, M.S.A. Hossain, Y. Yamauchi, A.A.I. Sina, A. Wuethrich, M. Trau
Journal: Journal of Thoracic Oncology (2023)
P2.09-07 Safety and Efficacy of Aumolertinib in Patients with advanced NSCLC Harboring Uncommon EGFR Mutations: Cohort 2 Updated
Authors: W.F. Fang, Q. Bu, Q.M. Wang, W.H. Zhao, L.P. Wang, X.R. Dong, P.F. Chen, Z.B. Wen, J. Jia, G.M. Jiang, L. Zhang
Journal: Journal of Thoracic Oncology (2023)
P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC
Authors: A. Horne, S. Brown, V. Coyle, K. Franks, A. Hassani, S. Harrow, M. Hatton, C. Hiley, J. Kendall, J.B. Oughton, P. Shaw, F. Walker, H. Yang, A.J. Chalmers, C. Faivre-Finn, A. Greystoke
Journal: Journal of Thoracic Oncology (2023)